Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders-Reference-Cited by-同舟云学术

Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders

Published:1999-07 Issue:1 Volume:98 Page:29-36
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Cohen Jeffrey A,Carter Jonathan L,Kinkel R.Philip,Schwid Steven R

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference33 articles.

1. Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses;Achiron;Neurology,1998

2. Long-term safety of azathioprine therapy in multiple sclerosis;Amato;Neurology,1993

3. Interferon-β1b treatment decreases tumor necrosis factor-α and increases interleukin-6 production in multiple sclerosis;Brod;Neurology,1996

4. Effects of steroids on Gd-enhancing lesions before and during recombinant beta interferon 1a treatment in relapsing remitting multiple sclerosis;Gasperini;Neurology,1998

5. Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests;Goodkin;Archives Phys. Med. Rehab.,1988

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of long-term intrathecal methotrexate in progressive forms of MS;Therapeutic Advances in Neurological Disorders;2019-01

2. HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patients;Journal of the Neurological Sciences;2015-05

3. Influencia del polimorfismo del gen de la APOE en la respuesta al tratamiento con interferón beta en esclerosis múltiple;Neurología;2011-04

4. Influence of APOE gene polymorphisms on interferon-beta treatment response in multiple sclerosis;Neurología (English Edition);2011

5. Gender Differences in Self-Reported Symptom Awareness and Perceived Ability to Manage Therapy with Disease-Modifying Medication Among Commercially Insured Multiple Sclerosis Patients;Journal of Managed Care Pharmacy;2010-04